Steve Lendaris is a full-service life science intellectual property lawyer; assisting clients with strategic patent counseling, post-grant proceedings before the U.S. Patent Trial and Appeal Board (PTAB), and intellectual property litigation. Clients, from universities and small start-ups to large multinational corporations, regularly turn to Steve for advice on a broad range of biotechnology-related issues, from therapeutic antibody development and manufacturing to novel strategies for nucleic acid sequencing. Steve is a frequent lecturer on the use of PTAB proceedings in the life sciences and has spoken extensively on the evolving standard of patent eligibility in the field.
Please log in again. The login page will open in a new tab. After logging in you can close it and return to this page.